Plasma, fasting and non-fasting (Biospecimen)

Go to Biospecimen classification
ID17
NamePlasma, fasting and non-fasting
ClassificationBiospecimens > Blood > Plasma

Publications with Plasma, fasting and non-fasting

TitleFirst authorYear
Validation of a food frequency questionnaire to assess intake of n-3 polyunsaturated fatty acids in subjects with and without Major Depressive DisorderSublette2011
Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US womenSun2007
Plasma concentrations of carotenoids and vitamin C are better correlated with dietary intake in normal weight than overweight and obese elderly subjectsVioque2007
Plasma phospholipid fatty acid composition as a biomarker of habitual dietary fat intake in an ethnically diverse cohortHodge2007
Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapyMeyerhardt2005
Plasma carotenoids, vitamin C, tocopherols, and retinol and the risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition cohortBakker2016
Plasma carotenoids, vitamin C, retinol and tocopherols levels and pancreatic cancer risk within the European Prospective Investigation into Cancer and Nutrition: a nested case-control study: plasma micronutrients and pancreatic cancer riskJeurnink2015
Plasma and dietary carotenoids and vitamins A, C and E and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and NutritionLeenders2014
Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)Allen2008
Plasma carotenoids, retinol, and tocopherols and postmenopausal breast cancer risk in the Multiethnic Cohort Study: a nested case-control studyEpplein2009
Association of plasma micronutrient levels and urinary isoprostane with risk of lung cancer: the multiethnic cohort studyEpplein2009
Plasma levels of carotenoids, retinol and tocopherol and the risk of gastric cancer in Japan: a nested case-control studyPersson2008
Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition studyKey2007
Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutritionJenab2006
Plasma carotenoids, retinol, and tocopherols and risk of breast cancerTamimi2005
Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses' health studiesSisti2015
Plasma carotenoids and risk of breast cancer over 20 y of follow-upEliassen2015
Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and NutritionRos2012
Circulating carotenoids, mammographic density, and subsequent risk of breast cancerTamimi2009
Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention TrialKristal2014
Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC studySawada2017
Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health StudySong2016
Circulating vitamin D in relation to cancer incidence and survival of the head and neck and oesophagus in the EPIC cohortFanidi2016
Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 YearsEliassen2016
Circulating Vitamin D Levels and Risk of Colorectal Cancer in WomenChandler2015
Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohortMuller2014
Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort studyKim2014
Plasma 25-hydroxyvitamin D concentration and lymphoma risk: results of the European Prospective Investigation into Cancer and NutritionLuczynska2013
Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control studyKuhn2013
Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studiesLee2011
Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study IIEliassen2011
Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective StudyOtani2007
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancerBertone-Johnson2005
Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancerPlatz2004
Plasma vitamin D metabolites and risk of colorectal cancer in womenFeskanich2004
Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)Jenab2006
Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohortMatejcic2017
Prediagnostic plasma pyridoxal 5'-phosphate (vitamin b6) levels and invasive breast carcinoma risk: the multiethnic cohortLurie2012
A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and NutritionChuang2011
Plasma folate, related genetic variants, and colorectal cancer risk in EPICEussen2010
Vitamins B2 and B6 and genetic polymorphisms related to one-carbon metabolism as risk factors for gastric adenocarcinoma in the European prospective investigation into cancer and nutritionEussen2010
Dietary B vitamin and methionine intakes and plasma folate are not associated with colorectal cancer risk in Chinese womenShrubsole2009
Prospective study of plasma vitamin B6 and risk of colorectal cancer in menLee2009
Plasma folate and risk of colorectal cancer in a nested case-control study: the Japan Public Health Center-based prospective studyOtani2008
Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in womenLin2008
The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and NutritionVollset2007
Plasma vitamin B6 and the risk of colorectal cancer and adenoma in womenWei2005
Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancerZhang2003
Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective studyHultdin2005
Untangling the role of one-carbon metabolism in colorectal cancer risk: a comprehensive Bayesian network analysisMyte2017
Vitamin B-6 and colorectal cancer risk: a prospective population-based study using 3 distinct plasma markers of vitamin B-6 statusGylling2017
Low folate levels are associated with reduced risk of colorectal cancer in a population with low folate statusGylling2014
Plasma vitamin B12 concentrations and the risk of colorectal cancer: a nested case-referent studyDahlin2008
Low folate levels may protect against colorectal cancerVan Guelpen2006
Carotenoids, alpha-tocopherols, and retinol in plasma and breast cancer risk in northern SwedenHulten2001
Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancerWu2011
Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer riskEussen2010
A prospective study of one-carbon metabolism biomarkers and cancer of the head and neck and esophagusFanidi2015
Circulating biomarkers of one-carbon metabolism in relation to renal cell carcinoma incidence and survivalJohansson2014
Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studiesLee2012
Pre-diagnostic plasma 25-hydroxyvitamin D levels and risk of non-melanoma skin cancer in womenLiang2012
Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohortsSchernhammer2007
Plasma 25-hydroxyvitamin D and risk of colorectal cancer after adjusting for inflammatory markersSong2014
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancerTworoger2007
Plasma 25-hydroxyvitamin D and risk of pancreatic cancerWolpin2012
A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancerWu2007
Plasma homocysteine and cysteine and risk of breast cancer in womenLin2010
Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity statusSong2016
Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERGGraff2017
Plasma isoflavones and risk of primary liver cancer in Japanese women and men with hepatitis virus infection: a nested case-control studyMichikawa2015
Plasma alkylresorcinols, biomarkers of whole-grain wheat and rye intake, and incidence of colorectal cancerKyro2014
Self-reported whole-grain intake and plasma alkylresorcinol concentrations in combination in relation to the incidence of colorectal cancerKnudsen2014
Plasma enterolactone and breast cancer risk in the Nurses' Health Study IIXie2013
Plasma isoflavone concentrations are not associated with gastric cancer risk among Japanese men and womenHara2013
Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPICTravis2012
Plasma isoflavones and the risk of lung cancer in women: a nested case-control study in JapanShimazu2011
Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case-control studyIwasaki2010
Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and NutritionTravis2009
Plasma tea polyphenols and gastric cancer risk: a case-control study nested in a large population-based prospective study in JapanSasazuki2008
Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health CenterKurahashi2008
Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study groupIwasaki2008
Prospective study of plasma enterolactone and prostate cancer risk (Sweden)Stattin2004
An incident case-referent study on plasma enterolactone and breast cancer riskHulten2002
A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC studyChajes2017
Plasma phytanic acid concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and NutritionPrice2010
Plasma 25-hydroxyvitamin D concentration and subsequent risk of total and site specific cancers in Japanese population: large case-cohort study within Japan Public Health Center-based Prospective Study cohortBudhathoki2018
Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study IIWang2014

Biomarker data

Measurements of biomarkers in Plasma, fasting and non-fasting

Concentration values

IDParent IDDepthSubject groupPopulationCountryCohortBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianConverted unitAdjustment typeAdjusted onRegressed onExpressed asPublication

Reproducibility values

IDExcretion IDSubject groupPopulationCountryCohortBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailArithmetic meanGeometric meanMedianUnitAdjusted onReproducibility sizeICCICC 95% CI lowerICC 95% CI upperCV% WSCV% BSVAR WSVAR BSPublication

Associations of biomarkers measured in Plasma, fasting and non-fasting and exposures

Correlation values

IDIntake IDExcretion IDSubject groupPopulationCountryCohortIntake Time definitionIntake Assessment methodIntakeIntake detailSupplement intakes included?Intake Arithmetic meanIntake Geometric meanIntake MedianIntake UnitIntake Adjusted onBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailBiomarker Arithmetic meanBiomarker Geometric meanBiomarker MedianBiomarker UnitBiomarker Adjusted onCorrelation sizeCorrelation typeCorrelation valueCorrelation 95% CI lowerCorrelation 95% CI upperCorrelation p-valueSignificant?Measurement adjustmentDeattenuated?CovariatesPublication

Metabolomic associations

IDIntake IDExcretion IDSubject groupPopulationCountryCohortNo. of subjectsIntake Assessment methodIntakeIntervention doseBiospecimenAnalytical methodBiomarkerStructural identificationFeature selectionArea under curveSensitivitySpecificityPLS-DA VIPBeta coefficientBeta coefficient p-valueANOVA p-valuePublication

Associations of biomarkers measured in Plasma, fasting and non-fasting and cancer risk

Cancer associations

IDExcretion IDSubject groupPopulationCountryCohortNo. of subjectsNo. of casesNo. of controlsBiospecimenAnalytical methodBiomarkerBiomarker detailCancerStudy designPublication